GB1180056A - New Lactic Ferment - Google Patents
New Lactic FermentInfo
- Publication number
- GB1180056A GB1180056A GB42684/67A GB4268467A GB1180056A GB 1180056 A GB1180056 A GB 1180056A GB 42684/67 A GB42684/67 A GB 42684/67A GB 4268467 A GB4268467 A GB 4268467A GB 1180056 A GB1180056 A GB 1180056A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bacteria
- lactic
- whole culture
- dried
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1,180,056. Medicines; lactic ferments. MARPHA SOC. D'ETUDES ET D'EXPLOITATION DEMARQUES. 19 Sept., 1967 [20 Sept., 1966], No. 42684/67. Heading A5B. A lactic ferment comprises a dried whole culture of antibiotic-resistant lactic bacteria which have been killed prior to the drying of the culture. Strains of Lactobacillus acidophilus, Streptococcus lactis and/or Lactobacillus bulgericus resistant to tetracycline, oxytetracyline or chloramphenicol are aerosically cultivated at 28-40C in a medium containing polypeptides and essential amino acids (liver extract and peptones), precursors of the Vitamin B complex (liver extract) and sugars (lactose or dry milk powder) until the concentration of bacteria reaches 10.5<SP>7</SP> per milli litre, the bacterial cultures are combined (where appropriate) and neutralized to pH 6.5, the bacteria are killed, and the whole culture is concentrated to a syrup and is then dried by lyophilisation or desiccation. The dried whole culture is compounded with an antibiotic (tetracycline, oxytetracycline or chloramphenicol) or sulphonamide (sulphaguanidine) and a pharmaceutical carrier, and these are put up in the form of a powder, granules, tablets, capsules or dilutable suspension.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR77047A FR6349M (en) | 1966-09-20 | 1966-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1180056A true GB1180056A (en) | 1970-02-04 |
Family
ID=8617507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB42684/67A Expired GB1180056A (en) | 1966-09-20 | 1967-09-19 | New Lactic Ferment |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE703712A (en) |
| ES (1) | ES345151A1 (en) |
| FR (1) | FR6349M (en) |
| GB (1) | GB1180056A (en) |
| LU (1) | LU54478A1 (en) |
| NL (1) | NL6712799A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2077101B (en) * | 1980-05-12 | 1984-08-08 | Kyokuto Fatty Acid Corp | Antiallergic composition containing streptococci |
-
1966
- 1966-09-20 FR FR77047A patent/FR6349M/fr not_active Expired
-
1967
- 1967-09-11 BE BE703712D patent/BE703712A/xx unknown
- 1967-09-15 LU LU54478D patent/LU54478A1/xx unknown
- 1967-09-18 ES ES345151A patent/ES345151A1/en not_active Expired
- 1967-09-19 NL NL6712799A patent/NL6712799A/xx unknown
- 1967-09-19 GB GB42684/67A patent/GB1180056A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6712799A (en) | 1968-03-21 |
| BE703712A (en) | 1968-02-01 |
| FR6349M (en) | 1968-10-07 |
| ES345151A1 (en) | 1968-10-16 |
| LU54478A1 (en) | 1967-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3320130A (en) | Medicament for colitis, gastroenteritis and enterocolitis | |
| CN113652359B (en) | Lactic acid bacteria freeze-dried powder, preparation method and freeze-dried protective agent thereof | |
| NZ248057A (en) | Bifidobacterium strains and pharmaceutical compositions containing them | |
| FI20012509A (en) | New strains of Lactobacillus and their use in the production of food, in particular oatmeal | |
| CN107164295A (en) | A kind of selenium-enriched microbe its preparation method and application | |
| Dukes et al. | Identification of Haemophilus vaginalis | |
| EP1840205A4 (en) | Bifidobacterium lactis 668 strain used for ar a component for food products, starters, medicinal and cosmetic agents | |
| KR101951893B1 (en) | Method for producing high concentration of probiotic active Lactobacillus paracasei SRCM102343 strain derived from traditional fermented food | |
| GB1180056A (en) | New Lactic Ferment | |
| GB1439738A (en) | Anti-pyrosis composition and process for the production thereof | |
| RU2280464C2 (en) | Method for preparing dry probiotic preparation "batsell" | |
| RU2091075C1 (en) | Complex bacterial preparation for treatment and prophylaxis of gastroenteric disease in animals | |
| US3632746A (en) | Dried stable anti-tumor preparations and process for preparing the same | |
| ES2104817T3 (en) | CULTURE LYOPHILIZATE CONTAINING MICROORGANISMS WITH PROLIFERATIVE STRAINS, PROCEDURE FOR THE PREPARATION AND USE. | |
| FR2215201A1 (en) | Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent | |
| Blizzard et al. | Selective inhibition of proline-induced pigmentation in washed cells of Serratia marcescens | |
| GB2072502A (en) | Antitumour agent comprising lactobacillus casei | |
| GB1061894A (en) | Therapeutically active bacterial preparations | |
| ES2264368B1 (en) | FOOD OR DIETETIC COMPLEMENT COMPOSED BY PRODUCTS FROM THE LIST OF MICROORGANISMS. | |
| Huhtanen | Pantethine and casein hydrolyzate in the growth of certain lactobacilli | |
| GB1208599A (en) | Method for the cultivation of lactobacteria | |
| JPS6363620A (en) | Mixture of three kinds of living bacteria | |
| Huhtanen et al. | Factors which increase acid production in milk by lactobacilli | |
| Verhaegen et al. | Endocarditis Caused by Nutritionally Defficient Streptococci | |
| Parker | Paired culture interaction of the oral microbiota |